Clinicopathological features | |
---|---|
Age (mean ± SD, year) | 53.75 ± 9.76 |
Sex (male/female) | 53/7 |
Location (proximal/middle/distal) | 16/12/32 |
Tumor size (< 5 cm, ≥ 5 cm) | 26/34 |
Bormann type (I/II/III/IV) | 5/14/31/10 |
T stage (T1/T2/T3/T4) | 3/13/4/40 |
N stage (N0/N1/N2/N3) | 19/18/9/14 |
TNM stage (I/II/III/IV) | 12/12/31/5 |
Histological grade (well/poor differentiated) | 17/43 |
Plasma miRNA 106b (median, range) | 2.465 (0.90–4.54) |
Plasma miRNA 93 (median, range) | 2.305 (0.60–4.00) |
Plasma miRNA 25 (median, range) | 2.145 (0.45–3.87) |
Tumor miRNA 106b (median, range) | 2.430 (0.73–4.45) |
Tumor miRNA 93 (median, range) | 2.880 (1.44–4.68) |
Tumor miRNA 25 (median, range) | 2.165 (0.52–3.85) |